Spots Global Cancer Trial Database for therapeutic allogeneic lymphocytes
Every month we try and update this database with for therapeutic allogeneic lymphocytes cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Melanoma or Metastatic Kidney Cancer | NCT00004135 | Kidney Cancer Melanoma (Skin) | filgrastim therapeutic all... cyclophosphamid... fludarabine pho... peripheral bloo... | 18 Years - 65 Years | University of Chicago | |
| Biological Therapy in Treating Patients With Advanced Myelodysplastic Syndrome, Acute or Chronic Myeloid Leukemia, or Acute Lymphoblastic Leukemia Who Are Undergoing Stem Cell Transplantation | NCT00052520 | Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... B-cell Adult Ac... B-cell Childhoo... Childhood Chron... Childhood Myelo... Chronic Myelomo... Essential Throm... Polycythemia Ve... Previously Trea... Recurrent Adult... Recurrent Adult... Recurrent Child... Recurrent Child... Refractory Anem... Refractory Anem... Relapsing Chron... Secondary Acute... T-cell Adult Ac... T-cell Childhoo... | therapeutic all... aldesleukin peripheral bloo... allogeneic bone... laboratory biom... gene expression... immunologic tec... flow cytometry polymerase chai... cytogenetic ana... staining method | - | Fred Hutchinson Cancer Center | |
| Irradiated Donor Lymphocytes in Treating Patients With Metastatic Kidney Cancer | NCT00176501 | Kidney Cancer | therapeutic all... | 18 Years - 75 Years | Rutgers, The State University of New Jersey | |
| Irradiated Donor Lymphocytes and Rituximab in Treating Patients With Relapsed or Refractory Lymphoproliferative Disease | NCT00176475 | Leukemia Lymphoma Multiple Myelom... | rituximab therapeutic all... | 18 Years - | Rutgers, The State University of New Jersey | |
| Allogeneic Peripheral Stem Cell Transplantation in Treating Patients With Stage IV Breast Cancer | NCT00020176 | Breast Cancer | filgrastim therapeutic all... cyclophosphamid... cyclosporine fludarabine pho... peripheral bloo... | 18 Years - 70 Years | National Cancer Institute (NCI) | |
| Fludarabine Phosphate, Low-Dose Total-Body Irradiation, and Peripheral Blood Stem Cell Transplant Followed by Donor Lymphocyte Infusion in Treating Older Patients With Chronic Myeloid Leukemia | NCT00003145 | Accelerated Pha... Childhood Chron... Chronic Myeloge... Chronic Phase o... Recurrent Disea... | Fludarabine Pho... Total-Body Irra... Nonmyeloablativ... Peripheral Bloo... Cyclosporine Mycophenolate M... Therapeutic All... Laboratory Biom... | - 74 Years | Fred Hutchinson Cancer Center | |
| Irradiated Donor Lymphocytes in Treating Patients With Metastatic Kidney Cancer | NCT00176501 | Kidney Cancer | therapeutic all... | 18 Years - 75 Years | Rutgers, The State University of New Jersey | |
| Stem Cell Transplantation in Patients With High-Risk and Recurrent Pediatric Sarcomas | NCT00043979 | Sarcoma | F-18 Fluorodeox... therapeutic all... cyclophosphamid... cyclosporine doxorubicin hyd... etoposide fludarabine pho... melphalan prednisone sirolimus tacrolimus vincristine sul... peripheral bloo... Filgrastim Peripheral Bloo... | 5 Years - 35 Years | National Institutes of Health Clinical Center (CC) | |
| Combination Chemotherapy, Total-Body Irradiation, Peripheral Stem Cell Transplantation, and Lymphocyte Infusion in Treating Patients With Stage IV Melanoma | NCT00006233 | Melanoma (Skin) | therapeutic all... cyclosporine fludarabine pho... mycophenolate m... peripheral bloo... radiation thera... | 18 Years - 64 Years | Fred Hutchinson Cancer Center | |
| Donor White Blood Cell Infusions and Interleukin-2 in Treating Patients Who Are Undergoing an Autologous Stem Cell Transplant for Relapsed Advanced Lymphoid Cancer | NCT00248430 | Graft Versus Ho... Leukemia Lymphoma Multiple Myelom... | aldesleukin therapeutic all... melphalan bone marrow abl... peripheral bloo... | 18 Years - 69 Years | Fred Hutchinson Cancer Center | |
| Allogeneic Transplantation Using Mini-Conditioning for Treatment of Stage IV Breast Cancer | NCT00006261 | Breast Cancer | therapeutic all... cyclophosphamid... docetaxel doxorubicin hyd... fludarabine pho... peripheral bloo... | 18 Years - 60 Years | Case Comprehensive Cancer Center | |
| Donor Stem Cell Transplant in Treating Older or Frail Patients With Hematologic Cancer | NCT00296023 | Chronic Myelopr... Leukemia Lymphoma Multiple Myelom... Myelodysplastic... | anti-thymocyte ... filgrastim therapeutic all... busulfan fludarabine pho... methotrexate tacrolimus nonmyeloablativ... peripheral bloo... | 18 Years - 75 Years | University of California, San Francisco | |
| Total-Body Irradiation Plus Stem Cell Transplantation And White Blood Cell Infusion in Treating Older Patients With Acute Myeloid Leukemia | NCT00005801 | Leukemia | therapeutic all... peripheral bloo... radiation thera... | 55 Years - 74 Years | University of Colorado, Denver | |
| Phase I Study of Cellular Immunotherapy for Recurrent/Refractory Malignant Glioma Using Intratumoral Infusions of GRm13Z40-2, An Allogeneic CD8+ Cytolitic T-Cell Line Genetically Modified to Express the IL 13-Zetakine and HyTK and to be Resistant to Glucocorticoids, in Combination With Interleukin-2 | NCT01082926 | Anaplastic Astr... Anaplastic Epen... Anaplastic Meni... Anaplastic Olig... Brain Stem Glio... Ependymoblastom... Giant Cell Glio... Glioblastoma Gliosarcoma Grade III Menin... Meningeal Heman... Mixed Glioma Pineal Gland As... Brain Tumor | therapeutic all... aldesleukin laboratory biom... positron emissi... | 18 Years - 70 Years | City of Hope Medical Center | |
| Low-Dose Total-Body Irradiation and Fludarabine Phosphate Followed By Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Stage IV Kidney Cancer | NCT00005851 | Recurrent Renal... Stage IV Renal ... | fludarabine pho... total-body irra... nonmyeloablativ... cyclosporine mycophenolate m... peripheral bloo... therapeutic all... laboratory biom... | - 74 Years | Fred Hutchinson Cancer Center | |
| Combination Chemotherapy, Total-Body Irradiation, Peripheral Stem Cell Transplantation, and Lymphocyte Infusion in Treating Patients With Stage IV Melanoma | NCT00006233 | Melanoma (Skin) | therapeutic all... cyclosporine fludarabine pho... mycophenolate m... peripheral bloo... radiation thera... | 18 Years - 64 Years | Fred Hutchinson Cancer Center | |
| Total-Body Irradiation Plus Stem Cell Transplantation And White Blood Cell Infusion in Treating Older Patients With Acute Myeloid Leukemia | NCT00005801 | Leukemia | therapeutic all... peripheral bloo... radiation thera... | 55 Years - 74 Years | University of Colorado, Denver | |
| Peripheral Stem Cell Transplant, White Blood Cell Infusions, Chemotherapy, and Radiation Therapy in Treating Patients With Recurrent Metastatic Cervical or Vaginal Cancer | NCT00005941 | Cervical Cancer Vaginal Cancer | therapeutic all... cyclosporine fludarabine pho... mycophenolate m... peripheral bloo... radiation thera... | - 64 Years | Fred Hutchinson Cancer Center | |
| Sunitinib and Irradiated Donor Lymphocytes in Treating Patients With Metastatic Kidney Cancer | NCT00853125 | Kidney Cancer | therapeutic all... sunitinib malat... | 18 Years - 75 Years | Rutgers, The State University of New Jersey | |
| Donor Stem Cell Transplant in Treating Young Patients With Myelodysplastic Syndrome, Leukemia, Bone Marrow Failure Syndrome, or Severe Immunodeficiency Disease | NCT00295971 | Congenital Ameg... Leukemia Myelodysplastic... Severe Congenit... | anti-thymocyte ... therapeutic all... fludarabine pho... thiotepa allogeneic bone... allogeneic hema... in vitro-treate... total-body irra... | 1 Year - 17 Years | University of California, San Francisco | |
| Allogeneic Stem Cell Transplant After ATG, High-Dose Melphalan, and Fludarabine for Patients With Breast Cancer | NCT00074269 | Breast Cancer | anti-thymocyte ... filgrastim graft-versus-tu... therapeutic all... cyclosporine fludarabine pho... melphalan methotrexate peripheral bloo... | 18 Years - 60 Years | University of California, San Diego | |
| Combination Chemotherapy and Total-Body Irradiation Followed by Peripheral Stem Cell or Bone Marrow Transplantation in Treating Patients With Acute Lymphoblastic Leukemia | NCT00027547 | Leukemia | therapeutic all... cyclosporine cytarabine fludarabine pho... methotrexate mycophenolate m... allogeneic bone... peripheral bloo... radiation thera... | - 75 Years | Fred Hutchinson Cancer Center | |
| Gene Therapy and Biological Therapy in Treating Patients With Ovarian Epithelial Cancer | NCT00019136 | Ovarian Cancer | MOv-gamma chime... aldesleukin therapeutic all... | 18 Years - | National Cancer Institute (NCI) | |
| Sunitinib and Irradiated Donor Lymphocytes in Treating Patients With Metastatic Kidney Cancer | NCT00853125 | Kidney Cancer | therapeutic all... sunitinib malat... | 18 Years - 75 Years | Rutgers, The State University of New Jersey | |
| Cellular Adoptive Immunotherapy in Treating Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndromes That Relapsed After Donor Stem Cell Transplant | NCT00107354 | Leukemia Myelodysplastic... | aldesleukin therapeutic all... therapeutic aut... cytarabine etoposide mitoxantrone hy... allogeneic bone... peripheral bloo... | 14 Years - | Fred Hutchinson Cancer Center | |
| Irradiated Donor Lymphocytes in Treating Patients With Metastatic Kidney Cancer | NCT00176501 | Kidney Cancer | therapeutic all... | 18 Years - 75 Years | Rutgers, The State University of New Jersey | |
| Melphalan and Stem Cell Transplant Before Total-Body Irradiation and Donor Stem Cell Transplant in Treating Patients With Stage I-III Multiple Myeloma | NCT00003954 | Refractory Mult... Stage I Multipl... Stage II Multip... Stage III Multi... | melphalan autologous hema... autologous bone... peripheral bloo... total-body irra... peripheral bloo... cyclosporine mycophenolate m... therapeutic all... | - 65 Years | Fred Hutchinson Cancer Center | |
| Donor Lymphocytes to Prevent Graft-Versus-Host Disease in Patients With Chronic Myeloid Leukemia | NCT00004878 | Graft Versus Ho... Leukemia | therapeutic all... cytarabine fludarabine pho... idarubicin methotrexate tacrolimus in vitro-treate... peripheral bloo... | 50 Years - 70 Years | Jonsson Comprehensive Cancer Center | |
| Therapeutic Allogeneic Lymphocytes and Aldesleukin in Treating Patients With High-Risk or Recurrent Myeloid Leukemia After Undergoing Donor Stem Cell Transplant | NCT00052598 | Accelerated Pha... Acute Myeloid L... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Blastic Phase C... Childhood Chron... Childhood Myelo... Recurrent Adult... Recurrent Child... Relapsing Chron... Secondary Acute... | therapeutic all... aldesleukin laboratory biom... flow cytometry | - | Fred Hutchinson Cancer Center | |
| Fludarabine and Cyclophosphamide in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Chronic Lymphocytic Leukemia or Waldenstrom's Macroglobulinemia | NCT00281983 | Chronic Lymphoc... | alemtuzumab anti-thymocyte ... filgrastim rituximab therapeutic all... busulfan cyclophosphamid... cyclosporine fludarabine pho... methotrexate mycophenolate m... peripheral bloo... radiation thera... | 18 Years - 65 Years | German CLL Study Group | |
| Donor Cellular Therapy After Cytarabine in Treating Patients With Intermediate-Risk Acute Myeloid Leukemia in Remission | NCT02587871 | Adult Acute Mye... Childhood Acute... | Cytarabine Laboratory Biom... Peripheral Bloo... Therapeutic All... G-CSF mobilized... | - 59 Years | University of Southern California | |
| Gene Therapy and Biological Therapy in Treating Patients With Ovarian Epithelial Cancer | NCT00019136 | Ovarian Cancer | MOv-gamma chime... aldesleukin therapeutic all... | 18 Years - | National Cancer Institute (NCI) | |
| Low-Dose Total-Body Irradiation and Fludarabine Phosphate Followed By Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Stage IV Kidney Cancer | NCT00005851 | Recurrent Renal... Stage IV Renal ... | fludarabine pho... total-body irra... nonmyeloablativ... cyclosporine mycophenolate m... peripheral bloo... therapeutic all... laboratory biom... | - 74 Years | Fred Hutchinson Cancer Center | |
| Ipilimumab After Allogeneic Stem Cell Transplant in Treating Patients With Persistent or Progressive Cancer | NCT00060372 | Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Atypical Chroni... Childhood Myelo... Chronic Myeloge... Disseminated Ne... Malignant Neopl... Ovarian Chorioc... Ovarian Embryon... Ovarian Immatur... Ovarian Mature ... Ovarian Mixed G... Ovarian Monoder... Ovarian Polyemb... Ovarian Yolk Sa... Previously Trea... Recurrent Adult... Recurrent Adult... Recurrent Adult... Recurrent Adult... Recurrent Adult... Recurrent Adult... Recurrent Adult... Recurrent Adult... Recurrent Grade... Recurrent Malig... Recurrent Mantl... Recurrent Neuro... Recurrent Ovari... Recurrent Ovari... Refractory Chro... Refractory Mult... Relapsing Chron... Stage I Multipl... Stage II Multip... Stage II Ovaria... Stage III Malig... Stage III Multi... Stage III Ovari... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea... Stage IV Breast... Stage IV Ovaria... Testicular Chor... Testicular Chor... Testicular Chor... Testicular Chor... Testicular Chor... Testicular Embr... Testicular Embr... Testicular Embr... Testicular Embr... Testicular Embr... Testicular Embr... Testicular Tera... Testicular Yolk... Testicular Yolk... Testicular Yolk... | ipilimumab therapeutic all... | 18 Years - | National Cancer Institute (NCI) | |
| Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Metastatic or Unresectable Kidney Cancer | NCT00027573 | Kidney Cancer | filgrastim therapeutic all... cyclophosphamid... fludarabine pho... methotrexate tacrolimus peripheral bloo... | - 60 Years | Alliance for Clinical Trials in Oncology | |
| Sunitinib and Irradiated Donor Lymphocytes in Treating Patients With Metastatic Kidney Cancer | NCT00853125 | Kidney Cancer | therapeutic all... sunitinib malat... | 18 Years - 75 Years | Rutgers, The State University of New Jersey | |
| Fludarabine and Cyclophosphamide in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Chronic Lymphocytic Leukemia or Waldenstrom's Macroglobulinemia | NCT00281983 | Chronic Lymphoc... | alemtuzumab anti-thymocyte ... filgrastim rituximab therapeutic all... busulfan cyclophosphamid... cyclosporine fludarabine pho... methotrexate mycophenolate m... peripheral bloo... radiation thera... | 18 Years - 65 Years | German CLL Study Group | |
| Fludarabine Phosphate and Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Acute Lymphoblastic Leukemia or Chronic Myelogenous Leukemia That Has Responded to Treatment With Imatinib Mesylate, Dasatinib, or Nilotinib | NCT00036738 | Adult Acute Lym... Adult B Acute L... Blastic Phase Childhood Acute... Childhood B Acu... Chronic Myeloge... Chronic Phase o... Recurrent Adult... Recurrent Child... Recurrent Disea... | Cyclosporine Dasatinib Fludarabine Pho... Imatinib Mesyla... Mycophenolate M... Nilotinib Nonmyeloablativ... Peripheral Bloo... Therapeutic All... Total-Body Irra... | - 70 Years | Fred Hutchinson Cancer Center | |
| Sargramostim Following Allogeneic Bone Marrow Transplantation in Treating Patients With Chronic Myelogenous Leukemia | NCT00002778 | Leukemia | sargramostim therapeutic all... allogeneic bone... in vitro-treate... | 18 Years - 65 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Melanoma or Metastatic Kidney Cancer | NCT00004135 | Kidney Cancer Melanoma (Skin) | filgrastim therapeutic all... cyclophosphamid... fludarabine pho... peripheral bloo... | 18 Years - 65 Years | University of Chicago | |
| Total-Body Irradiation Plus Stem Cell Transplantation And White Blood Cell Infusion in Treating Older Patients With Acute Myeloid Leukemia | NCT00005801 | Leukemia | therapeutic all... peripheral bloo... radiation thera... | 55 Years - 74 Years | University of Colorado, Denver | |
| Donor Stem Cell Transplant in Treating Older or Frail Patients With Hematologic Cancer | NCT00296023 | Chronic Myelopr... Leukemia Lymphoma Multiple Myelom... Myelodysplastic... | anti-thymocyte ... filgrastim therapeutic all... busulfan fludarabine pho... methotrexate tacrolimus nonmyeloablativ... peripheral bloo... | 18 Years - 75 Years | University of California, San Francisco | |
| Peripheral Stem Cell Transplantation in Treating Patients With Metastatic or Recurrent Kidney Cancer | NCT00025519 | Kidney Cancer | therapeutic all... fludarabine pho... mycophenolate m... tacrolimus thalidomide peripheral bloo... radiation thera... | 18 Years - 65 Years | Fox Chase Cancer Center | |
| Donor Lymphocyte Infusion in Treating Patients With Persistent, Relapsed, or Progressing Cancer After Donor Hematopoietic Cell Transplant | NCT00068718 | Blast Phase Chr... Recurrent Adult... Recurrent Adult... Recurrent Hodgk... Recurrent Non-H... Recurrent Plasm... | Therapeutic All... | - | Fred Hutchinson Cancer Center | |
| Mycophenolate Mofetil, Tacrolimus, Daclizumab, and Donor Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer | NCT00006350 | Leukemia Lymphoma Multiple Myelom... Myelodysplastic... | daclizumab therapeutic all... mycophenolate m... tacrolimus peripheral bloo... | 18 Years - 120 Years | University of Maryland, Baltimore | |
| Biological Therapy in Treating Patients With Multiple Myeloma That Has Recurred Following Bone Marrow Transplantation | NCT00003153 | Multiple Myelom... | therapeutic all... | 18 Years - 120 Years | Eastern Cooperative Oncology Group | |
| Study Of Two Non-Myeloablative Stem Cell Transplant Strategies For Low-Grade Lymphoma And CLL | NCT00041288 | Leukemia Lymphoma | therapeutic all... cyclophosphamid... cyclosporine fludarabine pho... methotrexate mycophenolate m... tacrolimus peripheral bloo... radiation thera... | 18 Years - 75 Years | University of Texas Southwestern Medical Center |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
